Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Saccomanni

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
European Journal of Medicinal Chemistry|February 13, 2014
1,2-Dihydro-2-oxopyridine-3-carboxamides: the C-5 substituent is responsible for functionality switch at CB2 cannabinoid receptorValentina Lucchesi, Teija Parkkari, Juha R Savinainen, et al.
Journal of Medicinal Chemistry|October 2, 2014
CB2-selective cannabinoid receptor ligands: synthesis, pharmacological evaluation, and molecular modeling investigation of 1,8-Naphthyridin-2(1H)-one-3-carboxamidesValentina Lucchesi, Dow P Hurst, Derek M Shore, et al.
European Journal of Medicinal Chemistry|May 4, 2015
New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activityClementina Manera, Anna Maria Malfitano, Teija Parkkari, et al.
Journal of Medicinal Chemistry|July 18, 2022
Design, Synthesis, and Biological Activity of New CB2 Receptor Ligands: from Orthosteric and Allosteric Modulators to Dualsteric/Bitopic LigandsFrancesca Gado, Rebecca Ferrisi, Beatrice Polini, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
European Journal of Medicinal Chemistry|February 13, 2014
1,2-Dihydro-2-oxopyridine-3-carboxamides: the C-5 substituent is responsible for functionality switch at CB2 cannabinoid receptorValentina Lucchesi, Teija Parkkari, Juha R Savinainen, et al.
Journal of Medicinal Chemistry|October 2, 2014
CB2-selective cannabinoid receptor ligands: synthesis, pharmacological evaluation, and molecular modeling investigation of 1,8-Naphthyridin-2(1H)-one-3-carboxamidesValentina Lucchesi, Dow P Hurst, Derek M Shore, et al.
European Journal of Medicinal Chemistry|May 4, 2015
New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activityClementina Manera, Anna Maria Malfitano, Teija Parkkari, et al.
Journal of Medicinal Chemistry|July 18, 2022
Design, Synthesis, and Biological Activity of New CB2 Receptor Ligands: from Orthosteric and Allosteric Modulators to Dualsteric/Bitopic LigandsFrancesca Gado, Rebecca Ferrisi, Beatrice Polini, et al.
Pageof 5